昭衍新药
(603127)
| 流通市值：237.08亿 | | | 总市值：281.83亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 报告期 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 911,854,340.56 | 902,060,508.84 | 662,232,173.6 | 676,571,156.45 |
| 交易性金融资产 | 1,718,323,008.81 | 1,575,189,890.2 | 1,503,832,762.56 | 1,495,071,027.91 |
| 应收票据及应收账款 | 196,590,017.22 | 166,857,549.94 | 187,032,668.78 | 198,669,231.02 |
| 其中：应收票据 | 15,461,561.71 | 18,447,865.38 | 27,877,996.51 | 19,757,152.34 |
| 应收账款 | 181,128,455.51 | 148,409,684.56 | 159,154,672.27 | 178,912,078.68 |
| 预付款项 | 33,422,034.95 | 27,699,486.84 | 24,052,384.62 | 66,473,403.33 |
| 其他应收款合计 | 5,812,482.45 | 6,853,276.25 | 7,285,709.55 | 8,170,222.64 |
| 存货 | 1,412,250,590.51 | 1,574,086,005.34 | 1,560,968,955.1 | 1,528,404,534.7 |
| 合同资产 | 135,919,627.74 | 90,528,150.05 | 93,231,641.26 | 104,715,217.02 |
| 一年内到期的非流动资产 | 791,566,765.36 | 914,502,143.91 | 1,187,478,933.82 | 940,288,560.33 |
| 其他流动资产 | 56,496,858.39 | 55,287,257.8 | 53,837,557.17 | 45,397,734.18 |
| 流动资产合计 | 5,262,235,725.99 | 5,313,064,269.17 | 5,279,952,786.46 | 5,063,761,087.58 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 80,940,000 | 91,000,000 | 91,000,000 | 91,000,000 |
| 其他非流动金融资产 | 639,991,823.45 | 736,418,708.22 | 683,833,974.72 | 631,009,195.44 |
| 固定资产 | 766,679,488.27 | 780,358,583.1 | 790,959,184.92 | 677,345,597.14 |
| 在建工程 | 280,423,945.25 | 293,487,606.81 | 286,538,078.69 | 394,629,147.57 |
| 生产性生物资产 | 668,392,322.32 | 389,641,354.24 | 376,212,526.95 | 373,378,624.23 |
| 使用权资产 | 16,235,435.55 | 27,073,312.1 | 35,209,874.97 | 44,254,815.65 |
| 无形资产 | 285,054,055.86 | 289,490,170.15 | 290,546,105.12 | 294,694,673.84 |
| 商誉 | 54,690,276.26 | 136,444,900.46 | 137,464,564.69 | 137,840,937.93 |
| 长期待摊费用 | 69,845,167.51 | 66,387,776.99 | 70,152,998.74 | 60,165,649.02 |
| 递延所得税资产 | 39,677,105.69 | 31,759,527.12 | 29,438,853.06 | 33,995,873.85 |
| 其他非流动资产 | 1,517,743,275.09 | 1,378,256,500.86 | 1,402,153,313.98 | 1,622,583,007.27 |
| 非流动资产合计 | 4,419,672,895.25 | 4,220,318,440.05 | 4,193,509,475.84 | 4,360,897,521.94 |
| 资产总计 | 9,681,908,621.24 | 9,533,382,709.22 | 9,473,462,262.3 | 9,424,658,609.52 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 73,958,454.81 | 54,546,282.68 | 52,821,291.98 | 44,537,300.58 |
| 应付账款 | 73,958,454.81 | 54,546,282.68 | 52,821,291.98 | 44,537,300.58 |
| 合同负债 | 854,240,187.33 | 978,965,145.04 | 896,149,406.79 | 871,306,662.06 |
| 应付职工薪酬 | 117,605,841.86 | 70,944,497.26 | 78,177,192.38 | 63,929,189.33 |
| 应交税费 | 19,670,519.18 | 10,582,527.29 | 10,956,908.69 | 14,419,001.11 |
| 其他应付款合计 | 71,103,817.12 | 74,967,371.77 | 95,682,870.92 | 68,160,052.25 |
| 应付股利 | - | - | 22,385,229 | - |
| 一年内到期的非流动负债 | 20,170,834.97 | 26,995,393.17 | 30,394,935.5 | 32,120,462.57 |
| 其他流动负债 | 3,838,275.43 | 3,472,772.98 | 2,965,834.25 | 3,186,695.53 |
| 流动负债合计 | 1,160,587,930.7 | 1,220,473,990.19 | 1,167,148,440.51 | 1,097,659,363.43 |
| 非流动负债: | | | | |
| 租赁负债 | 1,424,318.98 | 4,535,076.79 | 10,176,338.01 | 20,996,748.83 |
| 递延收益 | 72,738,875.47 | 74,654,484.55 | 76,845,177.89 | 79,606,862.99 |
| 递延所得税负债 | 121,806,335.01 | 112,696,921.01 | 114,225,830.16 | 117,189,711.21 |
| 非流动负债合计 | 195,969,529.46 | 191,886,482.35 | 201,247,346.06 | 217,793,323.03 |
| 负债合计 | 1,356,557,460.16 | 1,412,360,472.54 | 1,368,395,786.57 | 1,315,452,686.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 749,477,334 | 749,477,334 | 749,477,334 | 749,477,334 |
| 资本公积 | 5,237,665,882.34 | 5,237,665,882.34 | 5,237,665,882.34 | 5,237,665,882.34 |
| 减:库存股 | 230,570,134.79 | 230,570,134.79 | 230,898,376.4 | 230,898,376.4 |
| 其他综合收益 | 30,189,277.98 | 42,996,832.56 | 47,142,984.16 | 48,710,113.62 |
| 盈余公积 | 167,792,770.8 | 167,792,770.8 | 167,792,770.8 | 167,792,770.8 |
| 未分配利润 | 2,370,424,884.73 | 2,153,289,905.21 | 2,133,516,236.58 | 2,136,088,558.44 |
| 归属于母公司股东权益合计 | 8,324,980,015.06 | 8,120,652,590.12 | 8,104,696,831.48 | 8,108,836,282.8 |
| 少数股东权益 | 371,146.02 | 369,646.56 | 369,644.25 | 369,640.26 |
| 股东权益合计 | 8,325,351,161.08 | 8,121,022,236.68 | 8,105,066,475.73 | 8,109,205,923.06 |
| 负债和股东权益合计 | 9,681,908,621.24 | 9,533,382,709.22 | 9,473,462,262.3 | 9,424,658,609.52 |
| 公告日期 | 2026-03-31 | 2025-10-31 | 2025-08-27 | 2025-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |